The day started out with back and forth choppiness for most of the morning, but it looked like bullish-type consolidations as support held three times in the morning.

That resulted in a bounce back up to test the early the highs. A subsequent pullback and retest was successful and they then stair-stepped their way higher, just nominally taking out initial resistance on the S&P 500, but got very little follow-through and in the last hour rolled over and took back a large portion of the gains.

Net on the day the Dow was up just 4.76 at 8183.17, the S&P 500 gained 3.12 to 882.68, and the Nasdaq 100 up 3.45 to 1414.98. The Philadelphia Semiconductor Index (SOXX) had a real strong session, up 7.01 at 257.95, a gain of 2 ½ percent.

Advance-declines were positive by 3 to 2 on New York and by just 32 issues on Nasdaq. Up/down volume was about 2 to 1 positive on New York on total volume of under 1 billion. Nasdaq traded nearly 1.85 billion and had a 2 ½ to 1 positive volume ratio.

As a result of the positive technicals, most stocks on TheTechTrader.com board were up today.

But strange as it seems, even some of the ultrashorts were up today. The UltraShort Real Estate ProShares (SRS), despite the market gains, was ahead by 64 cents to 22.67. The Direxion Small Cap 3x Bear (TZA) also was up 34 cents to 26.67, quite possibly a bearish indication of things to come.

As a side note, the Direxion Financial Bull 3x Shares (FAS) and Direxion Financial Bear 3x Shares (FAZ) both had substantial reverse splits today, with the FAS splitting 1 for 5 and the FAZ splitting 1 for 10. The FAZ closed down 2.05 at 54.35 and the FAS was up 1.35 at 38.90.

Other gainers of note, Goldman Sachs (GS), in a generally firm financial sector, gained 4.66 to 143.21. Wells Fargo (WFC) was up 37 cents, and JP Morgan (JPM) up 91 cents. Morgan Stanley (MS) gained 38 cents.

The ag/chems were strong, with Potash (POT) up 2.91 to 92.51 and Mosaic (MOS) up 2.09 at 42.76.

Among the fractional gainers, Cornerstone Therapeutics (CRTX) gained 67 cents, and Dendreon (DNDN) 88 cents. OncoGenex Pharmaceuticals (OGXI) was up 35 cents, Rambus (RMBS) 45 cents. Yingli Green Energy (YGE) 59 cents, and Canadian Solar (CSIQ) 46 cents in a strong junior solar sector.

On the downside there were just a few fractional losers on our board today.

Stepping back and reviewing the hourly chart patterns, it was a tight choppy session with the indices bouncing around in the morning, rallying mid-day and then rolling over towards the end of the today, closing just fractionally ahead on the session, with mixed technicals.

Good trading!

Harry

For more of Harry Boxer, sign up for a FREE 15-Day Trial to his Real-Time Technical Trading Diary. Or sign up for a Free 30-Day Trial to his Top Charts of the Week service.

(c) 2009 AdviceTrade, Inc. All rights reserved. Distributed only by written permission of AdviceTrade and The Technical Trader at info@advicetrade.com . In using any portion of Harry Boxer's content, you agree to the terms and conditions governing the use of the service as described in our disclaimer at http://www.thetechtrader.com

Mr. Boxer's commentaries and index analysis represent his own opinions and should not be relied upon for purposes of effecting securities transactions or other investing strategies, nor should they be construed as an offer or solicitation of an offer to sell or buy any security. You should not interpret Mr. Boxer's opinions as constituting investment advice. Trades mentioned on the site are hypothetical, not actual, positions.

Harry Boxer Archive

Only logged in users are allowed to post comments. Register/ Log in

The Market Oracle is a FREE Financial Markets Forecasting & Analysis web-site.
(c) 2005-2024 MarketOracle.co.uk (Market Oracle Ltd) - Market Oracle Ltd asserts copyright on all articles authored by our editorial team and all comments posted. Any and all information provided within the web-site, is for general information purposes only and Market Oracle Ltd do not warrant the accuracy, timeliness or suitability of any information provided on this site. nor is or shall be deemed to constitute, financial or any other advice or recommendation by us. and are also not meant to be investment advice or solicitation or recommendation to establish market positions. We do not give investment advice and our comments are an expression of opinion only and should not be construed in any manner whatsoever as recommendations to enter into a market position either stock, option, futures contract, bonds, commodity or any other financial instrument at any time. We recommend that independent professional advice is obtained before you make any investment or trading decisions. By using this site you agree to this sites Terms of Use. From time to time we promote or endorse certain products / services that we believe are worthy of your time and attention. In return for that endorsement and only in the cases where you purchase directly though us may we be compensated by the producers of those products.